BNTC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Benitec Biopharma Inc (BNTC) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The lack of significant positive catalysts, weak financial performance, and absence of strong trading signals suggest holding off on this stock for now.
The MACD is positive but contracting, RSI is neutral at 43.344, and moving averages are converging, indicating no clear trend. The stock is trading below the pivot level of 11.857, with key support at 10.655 and resistance at 13.058.
Hedge funds are significantly increasing their buying activity, with a 599.83% increase over the last quarter.
No recent news or congress trading data. Financial performance remains weak with no revenue growth and negative net income. The stock has a low probability of significant short-term gains (30% chance of 6.73% gain in the next month).
In Q2 2026, revenue remained at 0 with no YoY growth. Net income improved slightly but remains negative at -11,837,000 (up 23.92% YoY). EPS is -0.26 with no YoY change. Gross margin is 0.
No analyst ratings or price target changes available for assessment.
